prognosis
Last reviewed 01/2018
There is an approximate 25% mortality during the acute phase of the disease. In infants who survive the clinical features gradually improve over a 6 month to two year period. These infants are prone to recurrent wheezing episodes, that are often associated with viral infections, during the first two years of life.